Shares of Illinois-based Aptinyx have plunged more than 67 percent in premarket trading after the co
Read More
The decision comes ahead of data readouts for two of the clinical candidates – mavacamten and MYK-49
Read More
Privately-held Tizona Therapeutics snagged $105 million in upfront cash as its cancer antibody TTX-0
Read More
Days ahead of the J.P. Morgan Healthcare Conference, Germany-based BioNTech extended its three-year-
Read More
Selecta Biosciences, based in Watertown, Mass., announced that as part of restructuring efforts it i
Read More
UroGen Pharma, based in New York, announced positive topline results from its Phase III OLYMPUS clin
Read More
According to the report by Startup Health Insights, investment in digital health has increased 14-fo
Read More